ペルーがアストラゼネカ社のコロナ・ワクチン採用を却下 データ提供なし、前払い、高価で必要量を確保できない、治験で死者が出た
他の製薬会社は多くのデータを提供したが、アストラゼネカ社は提供しなかった。他に安いワクチンがたくさんあると。
AstraZeneca’s vaccine rejected by Covid-stricken Peru over high costs and lack of data
23 Oct, 2020 11:47
https://www.rt.com/news/504360-astrazenica-peru-deal-rejected/
（前略）
Speaking on Thursday, Peruvian Prime Minister Walter Martos stated that the multinational pharmaceutical company AstraZenaca had not provided the government with enough information about the candidate vaccine, adding that the price was too high and the quantity available was limited.
They were offering us a very small quantity of vaccines for the country in comparison to other laboratories that are offering us larger quantities at lower costs.
Martos also claimed that AstraZeneca required a substantial advance payment that would be lost in the event the candidate vaccine did not meet the required safety standards.
The prime minister said the government had requested testing data from the pharmaceutical company, but it had not been forthcoming. He added that other firms had provided the requested data, but AstraZeneca had not.
His comments follow those of Minister of Health Pilar Mazzetti, who claimed the lack of information meant a prior agreement could not be reached. Mazzetti also highlighted the reported complications in the AstraZeneca vaccine trial, noting the death of a Brazilian participant earlier in the week and two cases of transverse myelitis in the UK.
（後略）
・・・採用を決めるも何も、評価の土俵にすら乗らなかったというニュースです。
データが存在しないのだから、まだワクチンと呼べないこの駄目な代物に、日本政府は必要量を確保するだけの高額な支払いをしたんでしょ。
国民のことを思っての医薬品調達ではなく、英米に対するゴマすり目的の外交上のお付き合いだね。血税を何だと思ってるんだか。
AstraZeneca’s vaccine rejected by Covid-stricken Peru over high costs and lack of data
23 Oct, 2020 11:47
https://www.rt.com/news/504360-astrazenica-peru-deal-rejected/
（前略）
Speaking on Thursday, Peruvian Prime Minister Walter Martos stated that the multinational pharmaceutical company AstraZenaca had not provided the government with enough information about the candidate vaccine, adding that the price was too high and the quantity available was limited.
They were offering us a very small quantity of vaccines for the country in comparison to other laboratories that are offering us larger quantities at lower costs.
Martos also claimed that AstraZeneca required a substantial advance payment that would be lost in the event the candidate vaccine did not meet the required safety standards.
The prime minister said the government had requested testing data from the pharmaceutical company, but it had not been forthcoming. He added that other firms had provided the requested data, but AstraZeneca had not.
His comments follow those of Minister of Health Pilar Mazzetti, who claimed the lack of information meant a prior agreement could not be reached. Mazzetti also highlighted the reported complications in the AstraZeneca vaccine trial, noting the death of a Brazilian participant earlier in the week and two cases of transverse myelitis in the UK.
（後略）
・・・採用を決めるも何も、評価の土俵にすら乗らなかったというニュースです。
データが存在しないのだから、まだワクチンと呼べないこの駄目な代物に、日本政府は必要量を確保するだけの高額な支払いをしたんでしょ。
国民のことを思っての医薬品調達ではなく、英米に対するゴマすり目的の外交上のお付き合いだね。血税を何だと思ってるんだか。
この記事へのコメント